GeneDx Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	99.68	123.93	400.57	118.96	115.01
Short-Term Investments	30.47	0	0	0	0
Cash & Cash Equivalents	130.15	123.93	400.57	118.96	115.01
Cash Growth	5.01%	-69.06%	236.73%	3.44%	-
Receivables	32.82	43.34	26.56	32.33	21.64
Inventory	8.78	13.67	33.46	24.96	15.98
Other Current Assets	10.6	31.68	22.96	-2.15	11.18
Total Current Assets	182.34	212.62	483.54	174.11	163.81
Property, Plant & Equipment	59.38	84.29	62.72	63.11	35.26
Long-Term Investments	0	0	0.9	0	0
Goodwill and Intangibles	172.63	186.65	0	0	0
Other Long-Term Assets	4.41	7.39	6.93	14.42	4.77
Total Long-Term Assets	236.42	278.32	70.55	77.53	40.03
Total Assets	418.76	490.94	554.09	251.64	203.84
Accounts Payable	38.84	88.47	47.32	28.16	19.26
Deferred Revenue	0	0	0.47	1.78	1.56
Current Debt	3.65	6.12	0	3.51	2.71
Other Current Liabilities	16.34	49.71	53.5	39.99	16.66
Total Current Liabilities	58.82	144.3	101.28	73.44	40.19
Long-Term Debt	115.63	66.26	11	39.75	22.28
Other Long-Term Liabilities	16.3	26.68	53.71	134.06	12.97
Total Long-Term Liabilities	131.92	92.94	64.71	173.81	35.25
Total Liabilities	190.74	237.24	165.99	247.25	75.44
Total Debt	119.27	72.38	11	43.26	24.99
Debt Growth	64.78%	558.04%	-74.57%	73.10%	-
Retained Earnings	-1,300.19	-1,124.42	-575.44	-330.05	-88.71
Comprehensive Income	0.43	0	0	0	0
Shareholders' Equity	228.02	253.71	388.1	-330.05	-88.71
Net Cash / Debt	10.88	51.55	389.57	75.71	90.02
Net Cash / Debt Growth	-78.90%	-86.77%	414.59%	-15.90%	-
Net Cash Per Share	0.45	5.04	118.95	488419.35	22504250.00
Working Capital	123.52	68.33	382.26	100.67	123.62
Book Value Per Share	9.38	24.78	118.50	-2122719.23	-23605907.40

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).